Keryx Biopharmaceuticals Inc fka KERX

[pickinstocks]

Don't blame you. I think what's holding this back, besides the MMs, is the possibility that the drug could still not make it to the market. But once this phase 3 ends, you will see an explosion in the share price. This is a company that has no real source of revenue, seeing as they have no drugs on the market. Think about the eps growth as perifosine sales increase. That share price estimate I posted the other day assumes only 5000 people with multiple myeloma will use the drug. That number is gotten from 50% of the 10,000 people that died last year from the disease. On top of that, they only take into account the 38% (from study results) of those 5000 people that will react to it favorably. This doesn't even include the revenue generated by the people that will try it for a couple of months and not react. I think it would not be at all unreasonable to expect to see well over a dollar per share in earnings once this hits the market. Especially because it is safe to assume there will be no dilution, as the company has stated on numerous occasions they have enough cash to fund the trials. The worst part for me isn't the waiting, it's that I don't have much money in it because I am only 23. While some people may make hundreds of thousands...I will fall well short of that mark! oh well have to start somewhere!